What I think is interesting, but I can’t prove i
Post# of 148177
(Total Views: 524)
Posted On: 04/01/2020 10:55:48 PM
What I think is interesting, but I can’t prove is a fact, is that many new investors probably don’t realize how good cancer results have been and that we should be getting more results soon. Even more exciting is that we should get results soon regarding metastatic cancers other than breast cancer, which will be a true testament to how well leronlimab works against metastatic cancer I’m general.
Oh, by the way, the company is also about to submit a BLA for HIV combo therapy that has an efficacy of over 90%.
One last thing, leronlimab has also shown very promising results for HIV mono therapy as well.
That is all.
Not really (NASH, MS, GvHD, etc.) but it’s late.
Oh, by the way, the company is also about to submit a BLA for HIV combo therapy that has an efficacy of over 90%.
One last thing, leronlimab has also shown very promising results for HIV mono therapy as well.
That is all.
Not really (NASH, MS, GvHD, etc.) but it’s late.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼